Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

HCATHCAT
26 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in HEALTH CATALYST INC

CITADEL ADVISORS LLC holds 453,214 shares of HCAT (HEALTH CATALYST INC), worth $901,896 as of 2026-Q2. This is a new position. HCAT represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$901,896

Current Shares

453,214

Total Value Change

-$892,104

Total Shares Change

+396,527

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
453,214
-
$901,8960.0%$1.99
34
2025-Q3
Exited
0
-100.0%
$00.0%$2.92
0
2025-Q2
Decreased
57,426
-64.6%
$216,4960.0%$3.81
0
2025-Q1
Decreased
162,241
-43.1%
$734,9520.0%$4.55
0
2024-Q4
Increased
284,928
+62.2%
$2M0.0%$7.01
37
2024-Q3
Increased
175,691
+10.3%
$1.4M0.0%$8.31
28
2024-Q2
Decreased
159,292
-23.4%
$1M0.0%$6.39
0
2024-Q1
Decreased
208,089
-13.9%
$1.6M0.0%$7.53
0
2023-Q4
Increased
241,708
+199.9%
$2.2M0.0%$9.26
42
2023-Q3
Increased
80,584
+479.6%
$815,5100.0%$10.12
40
2023-Q2
Decreased
13,903
-97.1%
$173,7880.0%$12.30
0
2023-Q1
Decreased
472,647
-45.2%
$5.5M0.0%$11.38
0
2022-Q4
Decreased
862,461
-12.6%
$9.2M0.0%$10.63
0
2022-Q3
Increased
986,437
+15.6%
$9.6M0.0%$10.17
32
2022-Q2
Increased
853,571
+80.3%
$12.4M0.0%$15.52
43
2022-Q1
Increased
473,535
+2417.2%
$12.4M0.0%$26.62
45
2021-Q4
Decreased
18,812
-45.0%
$746,0000.0%$40.56
0
2021-Q3
Decreased
34,208
-52.0%
$1.7M0.0%$50.13
0
2021-Q2
Decreased
71,347
-25.9%
$4M0.0%$55.98
0
2021-Q1
Decreased
96,214
-52.5%
$4.5M0.0%$46.28
0
2020-Q4
Increased
202,423
+10.6%
$8.8M0.0%$43.25
30
2020-Q3
Increased
183,088
+1629.4%
$6.7M0.0%$36.77
44
2020-Q2
Increased
10,587
+20.0%
$309,0000.0%$27.60
28
2020-Q1
New
8,823
-
$230,0000.0%$25.48
32
2019-Q4
Exited
0
-100.0%
$00.0%$34.12
0
2019-Q3
New
56,687
-
$1.8M0.0%$30.31
36

Other major holders of HCAT: SC US (TTGP), LTD., Capital Research Global Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used